C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2004
11/24/2004	CN1548442A Allan phosphonic acid as bone re-absorption inhibitor and its physiologically acceptable salt and their prepn
11/24/2004	CN1177083C Prepn. of onium hydroxides in electrochemical cell
11/24/2004	CN1176930C Method for production of phosphonomethylglycin
11/24/2004	CN1176929C Prepn of high-purity acephate powder
11/24/2004	CN1176885C C13 alcohol mixture and functionalized C13 alcohol mixture
11/23/2004	US6822115 Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
11/23/2004	US6822062 Supported group 8-10 transition metal olefin polymerization catalysts
11/23/2004	US6821944 Pumpable, surfactants
11/23/2004	US6821921 Catalyst compounds with β-diiminate anionic ligands and processes for polymerizing olefins
11/23/2004	US6821783 Transition metal complexes as linkers
11/23/2004	US6821761 Sphingolipid ceramide N-deacylase, methods for producing sphingolipids and sphingolipid derivatives, and sphingolipid ceramide N-deacylase gene
11/23/2004	CA2347280C Novel process for the preparation of nucleotides
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/18/2004	WO2004099292A1 A method of producing polymeric material
11/18/2004	WO2004099222A1 Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099098A1 Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete
11/18/2004	WO2004098772A2 Phospholane salts and their use in enantioselective hydrogenation
11/18/2004	WO2004098625A2 Medical use of inhibitors of glutaminyl and glutamate cyclases
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2003000700A3 Ascorbyl derivatives of carnitines and cosmetic compositions containing same
11/18/2004	US20040230076 Raising pH of crude material aqueous suspension until solution clears; precipitating with acid addition
11/18/2004	US20040230068 Process for manufacturing alkylphosphonate monoesters
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229846 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229842 Use of lipid conjugates in the treatment of diseases
11/18/2004	DE10318698A1 Verfahren zur Herstellung von Acylphosphinen Process for the preparation of acylphosphines
11/18/2004	CA2524915A1 Phospholane salts and their use in enantioselective hydrogenation
11/18/2004	CA2524052A1 Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/17/2004	EP1477493A1 Isotope coded affinity tags
11/17/2004	EP1477491A1 Process for manufacturing alkylphosphonate monoesters
11/17/2004	EP1477487A1 Improvement in the production of imidazole derivatives and novel intermediates of the derivatives
11/17/2004	EP1477477A1 Process for preparation of carotenoids
11/17/2004	EP1476453A1 Method for producing 6-alkoxy-(6h)-dibenz c,e] 1,2]-oxaphosphorines
11/17/2004	EP1476452A2 Acyl- and bisacylphosphine derivatives
11/17/2004	EP1476451A1 Use of certain diluents for making bisphosphonic acids
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	EP1165560B1 2-hydroxy methylcyclopro pylidenemethyl purines as antiviral agents
11/17/2004	EP1000071B1 Gaba-c receptor antagonists for stimulating memory capacity
11/17/2004	CN1546498A Method for separation and purification of grape-seed lecithin
11/17/2004	CN1546497A Method for separation and purification of wood-frog-egg lecithin
11/17/2004	CN1546496A Method for separation and purification of lecithin and cephalin
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546446A Fluorene derivatives and their application
11/17/2004	CN1546371A Process for producing orthophosphorous acid from high boiling byproducts of dialkyl ester phosphite
11/17/2004	CN1176092C Biphosphonate
11/17/2004	CN1176091C Vitamin D precursor of phosphine oxide
11/16/2004	US6818793 Method for production of n-phosphonomethylglycine
11/16/2004	US6818787 Prodrugs of GABA analogs, compositions and uses thereof
11/16/2004	US6818770 Tricyclic phosphinine ligands have two phosphorus centers that may be substituted with a variety of hetero atoms or alkyl substituents to modify ligand characteristcs of the phosphinine; used as hydroformylation catalyst with metal
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004	US6818633 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818450 Use of infrared spectroscopy for on-line process control and endpoint detection
11/16/2004	US6818394 High density immobilization of nucleic acids
11/16/2004	US6818199 Intravenous delivery of radiographic nanoparticulate contrast agent
11/16/2004	CA2456752A1 Process for manufacturing alkylphosphonate monoesters
11/11/2004	WO2004096947A1 Organic polymer light-emitting element material having gold complex structure and organic polymer light-emitting element
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	WO2004096753A1 ASYMMETRIC-SYNTHESIS CATALYST BASED ON CHIRAL BR&dollar;NSTED ACID AND METHOD OF ASYMMETRIC SYNTHESIS WITH THE CATALYST
11/11/2004	WO2004096752A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
11/11/2004	WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
11/11/2004	WO2004096286A2 Antiviral phosphonate analogs
11/11/2004	WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004	WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004	WO2004096234A2 Kinase inhibitor phosphonate conjugates
11/11/2004	WO2004096233A2 Nucleoside phosphonate conjugates
11/11/2004	WO2004096131A2 Inhibitors of akt activity
11/11/2004	WO2004085447A3 Thiophosphine compounds and method of making polymerisable compositions containing them and their use for making ophtalmic lenses
11/11/2004	WO2004058402A3 Process for the recovery of phosphorus and iodine containing catalyst components
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	US20040225147 Contacting formaldehyde, phosphorous acid and an amine to produce a phosphonomethylation reaction product; contacting with water and an oxidizing gas in the presence of a catalyst, contactingformylphosphonic acid derivative with glycine, reducing to produce N-(phosphonomethyl) glycine
11/11/2004	US20040225146 Tyrosine phosphatase scafold synthesis
11/11/2004	US20040225145 Process for producing phosphite
11/11/2004	US20040225131 reacting formaldehyde with alkylamine; acidification in water, glyooxal solution; separation
11/11/2004	US20040225127 Process for manufacture of fosinopril sodium
11/11/2004	US20040225119 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis
11/11/2004	US20040225092 Contacting at least one acrylic monomer under polymerization conditions with a catalyst containing a copper chloride (CuCl) complexed with a ligand containing mono or bicyclic phosphours ring
11/11/2004	US20040225080 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	US20040222401 Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors
11/11/2004	DE10318981A1 New metal-interacting amphiphilic compounds e.g. useful as corrosion inhibitors, adhesion promoters, primers, passivation agents or conversion layer formers
11/11/2004	DE10317895A1 Use of 1,3,4-oxa- or thiadiazol-2-yl-(thio)phosphoric acid triamide derivatives, as urease inhibitors for preventing decomposition of urea in fertilizers or feedstuffs
11/11/2004	DE10142014B4 Verfahren zur Herstellung von Phosphatidylserin Process for the preparation of phosphatidylserine
11/11/2004	CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	CA2523582A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
11/11/2004	CA2523083A1 Antiviral phosphonate analogs
11/11/2004	CA2522845A1 Kinase inhibitor phosphonate conjugates
11/11/2004	CA2522431A1 Inhibitors of akt activity
11/11/2004	CA2519840A1 Anti-cancer phosphonate analogs
11/10/2004	EP1475384A1 Process for preparing phosphorus compounds
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1475360A1 use of esters of phosphorus-oxygen acids containing alkoxy groups as corrosion inhibitor for steel reinforced concrete

1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 554